Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer
ConditionThoracic Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorThe New York Proton Center
About this trial
This is an observational study involving the collection of patient-generated health data using an Apple Watch, a home pulse oximeter, and a smartphone during a course of proton beam radiotherapy for lung cancer. The study period over which this information is collected will range from the day of study enrollment until two weeks after radiotherapy completion. Subjects will complete a short satisfaction survey at the end of the study period. Other information that is collected as part of routine care for this patient population will be extracted from subjects' medical records during the study period and afterwards.
Eligibility criteria
Qualifiers
Plan for fractionated (≥15 treatments) proton beam thoracic radiotherapy with curative intent for lung cancer
Non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) histology is permitted.
Concurrent chemotherapy is permitted but not required..
Previous thoracic radiotherapy is allowed.
Disqualifiers
Ongoing treatment for another cancer that is expected to affect the toxicity profile of thoracic radiotherapy
Pregnancy or women of childbearing potential and men who are sexually active and not willing/able to use medically acceptable forms of contraception; this exclusion is necessary because the treatment involved in this study may be significantly teratogenic
Trial design
Treatments tested in this trial
- Proton Beam Radiation with or without concurrent chemotherapy
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov